New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2022, Updated recommendations on treatment of adolescents and children with chronic HCV infection: policy brief.
View latest version (2022)Bibliographic Info
GuidelineGuidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
Year of Publication2018
Issuing InstitutionWorld Health Organization
Recommendation
Status
Retired
Recommended in favor
Conditional
Certainty of evidence
Moderate
WHO recommends the use of pangenotypic direct-acting antiviral regimens for the treatment of persons with chronic HCV infection aged 18 years and above
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations
Year2022
InstitutionWHO